Assessing Immunogenicity Risk of Peptide Drugs: Generic Drug Perspective
Author/sPang, Eric
Date:01/01/1970
Meeting Name:FDA and the Center for Research on Complex Generics (CRCG) Workshop on Scientific and Regulatory Considerations for Assessment of Immunogenicity Risk for Generic Peptide and Oligonucleotide Drug Products
State:MD
City:Rockville